Hirsch Andrew 4
4 · C4 Therapeutics, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
Hirsch Andrew
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-02-14+103,400→ 217,301 total - Award
Stock Option (Right to Buy)
2024-02-14+465,500→ 465,500 totalExercise: $7.31Exp: 2034-02-13→ Common Stock (465,500 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025.
- [F2]The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024.